sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the Coronary Artery Bypass Graft Market was valued at USD 14.5 billion in 2023 and will surpass USD 25.3 billion by 2030; growing at a CAGR of 8.2% during 2024 - 2030.
The Off-Pump Coronary Artery Bypass Graft (CABG) segment is expected to witness significant growth due to its numerous advantages over traditional CABG procedures. Unlike traditional CABG, off-pump surgery is performed while the heart is still beating, eliminating the need for a heart-lung machine. This technique reduces the risks associated with cardiopulmonary bypass, such as stroke, infection, and prolonged recovery times. Patients undergoing off-pump surgery tend to experience faster recovery and shorter hospital stays, which is particularly beneficial for older patients and those with high surgical risks.
Additionally, the increasing demand for minimally invasive and less traumatic surgical interventions is further boosting the growth of the off-pump CABG segment. As healthcare providers and patients alike seek to minimize postoperative complications and improve patient outcomes, off-pump procedures are becoming more widely adopted, particularly in developed healthcare systems. With advancements in surgical tools and techniques, the segment is poised to gain traction in the global CABG market, offering a safer and more efficient alternative to traditional open-heart surgery.
North America is anticipated to remain the largest market for coronary artery bypass graft procedures, driven by the region's advanced healthcare infrastructure and high prevalence of coronary artery disease (CAD). The aging population in the U.S. and Canada, coupled with increasing risk factors such as obesity, hypertension, and diabetes, has led to a growing number of CABG procedures being performed in the region. Moreover, the presence of leading medical device manufacturers and research institutions supports the continuous development of innovative surgical techniques and tools for CABG procedures.
In addition to technological advancements, favorable reimbursement policies and government healthcare initiatives contribute to the region's dominance in the CABG market. North America also benefits from a highly skilled medical workforce and well-established cardiac care centers, ensuring high-quality treatment and patient care. As the demand for cardiovascular surgeries continues to rise, North America is expected to maintain its leadership position in the global CABG market, with ongoing efforts to improve surgical outcomes and patient safety.
The report focuses on estimating the current market potential in terms of the total addressable market for all the segments, sub-segments, and regions. In the process, all the high-growth and upcoming technologies were identified and analyzed to measure their impact on the current and future market. The report also identifies the key stakeholders, their business gaps, and their purchasing behavior. This information is essential for developing effective marketing strategies and creating products or services that meet the needs of the target market. The report also covers a detailed analysis of the competitive landscape which includes major players, their recent developments, growth strategies, product benchmarking, and manufacturing operations among others. Also, brief insights on start-up ecosystem and emerging companies is also included as part of this report.
The report will help you answer some of the most critical questions in the Coronary Artery Bypass Graft Market. A few of them are as follows:
Report Features |
Description |
Market Size (2023) |
USD 14.5 billion |
Forecasted Value (2030) |
USD 25.3 billion |
CAGR (2024 – 2030) |
8.2% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Coronary Artery Bypass Graft Market By Type (Traditional Coronary Artery Bypass Graft, Off-Pump Coronary Artery Bypass Graft, Minimally Invasive Direct Coronary Artery Bypass (MIDCAB), Endoscopic Vessel Harvesting (EVH)), By Procedure (Single Bypass Surgery, Double Bypass Surgery, Triple Bypass Surgery, Quadruple Bypass Surgery), By Material (Saphenous Vein Grafts, Internal Thoracic Artery Grafts, Radial Artery Grafts), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Research & Academic Institutions) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Coronary Artery Bypass Graft Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Traditional |
4.2. Off-Pump |
4.3. Minimally Invasive Direct |
4.4. Endoscopic Vessel Harvesting (EVH) |
5. Coronary Artery Bypass Graft Market, by Procedure (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Single Bypass Surgery |
5.2. Double Bypass Surgery |
5.3. Triple Bypass Surgery |
5.4. Quadruple Bypass Surgery |
6. Coronary Artery Bypass Graft Market, by Material (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Saphenous Vein Grafts |
6.2. Internal Thoracic Artery Grafts |
6.3. Radial Artery Grafts |
6.4. Others |
7. Coronary Artery Bypass Graft Market, by End-User (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Hospitals |
7.2. Ambulatory Surgical Centers |
7.3. Cardiac Centers |
7.4. Research & Academic Institutions |
8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America Coronary Artery Bypass Graft Market, by Type |
8.2.7. North America Coronary Artery Bypass Graft Market, by Procedure |
8.2.8. North America Coronary Artery Bypass Graft Market, by Material |
8.2.9. North America Coronary Artery Bypass Graft Market, by End-User |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US Coronary Artery Bypass Graft Market, by Type |
8.2.10.1.2. US Coronary Artery Bypass Graft Market, by Procedure |
8.2.10.1.3. US Coronary Artery Bypass Graft Market, by Material |
8.2.10.1.4. US Coronary Artery Bypass Graft Market, by End-User |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Abbott |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Artivion |
10.3. B. Braun Melsungen |
10.4. Boston Scientific |
10.5. Edwards Lifesciences |
10.6. Getinge |
10.7. Johnson & Johnson |
10.8. LeMaitre Vascular |
10.9. LivaNova |
10.10. Medtronic |
10.11. Stryker |
10.12. Teleflex |
10.13. Terumo |
10.14. W. L. Gore & Associates |
10.15. Zimmer Biomet |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Coronary Artery Bypass Graft Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Coronary Artery Bypass Graft Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the coronary artery bypass graft ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Coronary Artery Bypass Graft Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.